Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazole in stable adult kidney transplants

被引:36
作者
Foradori, A
Mezzano, S
Videla, C
Pefaur, J
Elberg, A
机构
[1] Catholic Univ, Sch Med, Ctr Diagnost, Santiago, Chile
[2] Univ Austral Chile, Sch Med, Valdivia, Chile
[3] Univ Chile, Sch Med, Vina del Mar, Chile
[4] Univ Chile, Sch Med, Santiago, Chile
关键词
D O I
10.1016/S0041-1345(98)00393-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1685 / 1687
页数:3
相关论文
共 14 条
[11]  
Sharma Atul, 1997, Pediatric Research, V41, p283A
[12]   ERYTHROMYCIN BREATH TEST PREDICTS ORAL CLEARANCE OF CYCLOSPORINE IN KIDNEY-TRANSPLANT RECIPIENTS [J].
TURGEON, DK ;
NORMOLLE, DP ;
LEICHTMAN, AB ;
ANNESLEY, TM ;
SMITH, DE ;
WATKINS, PB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (05) :471-478
[13]  
Videla C, 1997, REV MED CHILE, V125, P438
[14]   PREVENTION OF POSTTRANSPLANT ACUTE TUBULAR-NECROSIS BY THE CALCIUM-ANTAGONIST DILTIAZEM - A PROSPECTIVE RANDOMIZED STUDY [J].
WAGNER, K ;
ALBRECHT, S ;
NEUMAYER, HH .
AMERICAN JOURNAL OF NEPHROLOGY, 1987, 7 (04) :287-291